Atlas Trials

Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins

Clinical trial NCT02230163 · UNKNOWN

Trial details

NCT number
NCT02230163
Sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chikungunya Virus Infection
Start date
2014-09-01
Primary completion
2015-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.